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Summary
Objective: To discriminate between changes in biomarkers with exercise compared to changes in biomarkers with osteoarthritis (OA) in
exercising horses.
Method: Sixteen, 2-year-old horses were randomly assigned either to an exercise-alone (n¼ 8) or OA-affected (also exercised) (n¼ 8) group.
All horses had both mid-carpal joints arthroscoped and OA induced in one mid-carpal joint in the OA-affected joints of OA-affected horses.
Two weeks after surgery all horses commenced a strenuous exercise program on a high-speed treadmill. Clinical outcomes and synovial ﬂuid
and serum biomarkers, were evaluated weekly. Synovial and serum biomarkers evaluated were epitope CS846 (CS846), epitope CPII (CPII),
glycosaminoglycans (GAGs), epitope Col CEQ (Col CEQ) (a marker of type II collagen degradation), type I and II collagen degradation frag-
ments (C1,2C), osteocalcin, C-terminal of bone type I collagen (CTX1), type I collagen (Col I) and (synovial ﬂuid only of cartilage) prostaglan-
din E2 (PGE2) levels. Horses were euthanized at day 91 and their joints assessed grossly, histopathologically, and histochemically.
Results: Exercise induced a signiﬁcant increase in synovial ﬂuid CS846, CPII, GAG, Col CEQ, C1,2C, osteocalcin and Col I concentrations.
There was a signiﬁcant increase in synovial ﬂuid CS846, CPII, Col CEQ, C1,2C, osteocalcin, Col I and PGE2 concentrations in OA-affected
joints compared to exercise-alone joints. The concentration of serum CS846, CPII, GAG, osteocalcin, C1,2C and Col I increased with exer-
cise. For each of these biomarkers there was also a statistically signiﬁcant increase in serum biomarker levels in OA-affected horses com-
pared to exercise-alone horses.
Conclusions: Six synovial ﬂuid and serum biomarkers were useful in separating early experimental OA from exercise alone but synovial ﬂuid
CTX1 and serum Col CEQ and CTX1 were not.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Release of differentmacromolecules and their fragments into
synovial ﬂuid and serum follow the anabolic and catabolic
processes in the cartilage1e9. Biomarkers that provide spe-
ciﬁc information about alterations in cartilage matrix anabo-
lism or catabolism are designated as direct biomarkers10.
As biochemical alterations caused by osteoarthritis (OA) in-
volve dynamic processes within all elements that constitute
the joint, these mediators and products of tissue metabolism
originate from cartilage, synovial membrane, and subchon-
dral bone. Biomarkers can potentially be used to: (1) clarify
pathobiological processes in the joint; (2) differentiate diag-
nostically between affected and non-affected joints and dis-
tinguish the degree of degradation in articular cartilage; (3)aPresent address: Billinghurst is at the School of Health Sciences,
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1196monitor the response to therapy; and (4) prognosticate. An
experimental model of OA has been used by the authors
for all four purposes11e13.
Synovial ﬂuid and serum biomarkers have proven useful
in the diagnosis of equine bone and joint disease14. Initial
work in the authors’ laboratory used biomarkers developed
in Dr Robin Poole’s laboratory15 and showed synovial ﬂuid
epitope CS846 and total protein levels were signiﬁcantly
higher in joints in clinical cases of osteochondral fragmenta-
tion (OCF) in the carpus and that synovial ﬂuid total protein
and CS846 epitope concentrations were linearly related to
the grade of fragmentation16. Of equal signiﬁcance serum
epitope CS846 and CPII concentrations were signiﬁcantly
higher in horses with OCF than in control horses.
Biomarkers have been used to evaluate the response
to therapy in an equine OA-exercise model but the
confounding effects of exercise require clariﬁcation. Other
studies have shown both increases in certain markers
with exercise17e19 as well as decreases with other
biomarkers with exercise20e22. In order to discriminate
between changes in biomarkers with exercise compared
to changes of biomarkers with OA in exercising horses
the following study was designed in which both synovial
ﬂuid and serum biomarkers were assessed.
1197Osteoarthritis and Cartilage Vol. 16, No. 10MethodsEXPERIMENTAL DESIGNFollowing approval by the Colorado State University Animal Care and Use
Committee 16 2-year-old horses free of lameness and with radiographically
clinically normal carpal joints were used in the study. The horses were ran-
domly assigned to either an exercise-alone (n¼ 8) or OA-affected (also ex-
ercised) (n¼ 8) group. All horses were exercised (see below) for the ﬁrst 21
days. On day 21, horses in the exercise control had both mid-carpal joints
arthroscopically examined under general anesthesia. Horses in the OA-
affected group had both mid-carpal joints arthroscoped and OA induced in
one middle carpal joint (brieﬂy an 8-mm osteochondral fragment is created
on the distal radial carpal bone and then the defect burred back to a
15-mm defect with the debri left in the joint as previously described11); the
other sham operated joint was designated as the control joint. The mid-
carpal joints in the exercise-alone groups were also arthroscoped to conﬁrm
that they were normal.EXERCISEHorses were housed in a stall (3.65 3.65 m) unless otherwise noted.
Horses were exercised on a high-speed treadmill 5 days each week for
the ﬁrst 21 days; treadmilling was recommenced at day 35 (stall rested after
surgery days 22e34) and continued until the end of the study (day 91). Each
day, the horses underwent trotting (16e19 km/h) for 2 min, galloping (approx.
32 km/h) for 2 min, followed by trotting (16e19 km/h) for 2 min to simulate the
strenuous exercise of race training.ASSESSMENT OF CLINICAL OUTCOMESFor each horse, clinical examinations of both forelimbs were performed bi-
weekly from prior to day 0 (baseline) throughout the study period. These in-
cluded lameness graded on a scale of 0e523, ﬂexion of the carpal joint
followed by the horse trotting as an indicator of increase in pain at the trot,
response to ﬂexion graded on a scale of 0e4, and mid-carpal joint effusion
graded on a scale of 0e4 as previously described11. All outcome parameters
were assessed by a board certiﬁed large animal surgeon (a specialist in
equine lameness) who was unaware of treatment assignments.IMAGINGFor each horse, there were radiographic evaluations of both carpi as well
as nuclear scintigraphy, computed tomography and magnetic resonance im-
aging studies done. The results will be presented in a separate manuscript.COLLECTION OF SYNOVIAL FLUID AND SERUMBeginning on day 0 until the end of the study (day 91), a jugular vein blood
sample as well as synovial ﬂuid sample (both middle carpal joints) was asep-
tically aspirated once per week (except week 7, 9, and 11) from each horse
in both groups. Serum from the blood sample was stored at 80C for further
analysis. Synovial ﬂuid (2e4 mL) was directly aspirated from the joints by
use of a 20-gauge needle and syringe. Samples were placed in tubes con-
taining ethylenediaminetetraacetic acid (EDTA) for routine synovial ﬂuid
analysis (total protein concentration, cytologic evaluation, and total WBC
count) or stored at 80C for biochemical/biomarker protein analysis.SYNOVIAL FLUID AND SERUM BIOMARKERSSeven biomarker protein assays were performed on both serum and sy-
novial ﬂuid samples collected. Concentrations of the epitope CS846 were
measured by a commercial enzyme linked immunosorbant assay (ELISA)
kit (IBEX Diagnostics, Montreal, Quebec, Canada) as a marker of aggrecan
synthesis6,24. Concentrations of the epitope CPII were measured by using
a commercial ELISA kit (IBEX Diagnostics, Montreal, Quebec, Canada) as
a measure of type II collagen synthesis25,26. Both of these assays were pre-
viously validated in the investigator’s laboratory for use in the horse27. A
modiﬁed 1,9-dimethylmethylene blue dye-binding assay was used on papain
digested samples to determine glycosaminoglycan (GAG) concentration as
a marker of cartilage matrix degradation (GAG)28. Concentrations of the epi-
tope Col CEQ were measured using an ELISA developed for the horse to
measure type II collagen degradation27. Concentrations of osteocalcin
were estimated using a Metra Osteocalcin EIA Kit (Quidel Corporation,
San Diego, CA, USA), which has been validated as a serum marker of
bone formation29. Bone turnover in serum was estimated based on the re-
lease of the C-terminal of type I collagen (CTX1), a measure of bone speciﬁc
type I collagen (Col I). This assay has previously been used successfully in
horses (CrossLaps ELISA Nordic Bioscience Diagnostics, Denmark)30,31.A competitive ELISA was used to estimate concentrations of the epitope
Col 2-3/4Cshort which has been validated as measuring both type I and II
collagen degradation fragments25 (now called C1,2C, IBEX Diagnostics,
Montreal, Quebec, Canada32). By subtracting the concentration of Col
CEQ from the concentration of C1,2C, Col I degradation in cartilage could
indirectly be determined15. Synovial ﬂuid concentration of PGE2 was
assessed following extraction of PGE2 from synovial ﬂuid and estimated
by use of a commercially available high-sensitivity enzyme immunoassay
kit (PGE2 ELISA, Assay Design, Ann Arbor, MI, USA).GROSS OBSERVATION OF JOINTSAt the end of the study, all horses were euthanized by the use of sodium
pentobarbital overdose. For each horse, a necropsy examination was per-
formed during which both middle carpal joints were speciﬁcally examined
for degree and location of articular cartilage ﬁbrillation or erosion and synovial
membrane hyperemia as previously described (gross pathology score)11.HISTOLOGIC EXAMINATIONSAt necropsy, samples of synovial membrane and joint capsule were col-
lected from the dorsomedial region of the joint, placed in neutral-buffered
10% formalin and 5-mm sections of the tissue samples were prepared as pre-
viously described11. An evaluator, who was unaware of treatment assign-
ments, evaluated the sections of synovial membrane and ﬁbrous joint
capsule for cellular inﬁltration, synovial intimal hyperplasia, subintimal edema,
subintimal ﬁbrosis, and subintimal vascularity (each outcome graded 0e4)20.
Articular cartilage specimens were collected from an area directly adja-
cent to the osteochondral fragment (or equivalent in control joints), a portion
of the opposing articulating surface (third carpal bone), and a remote location
(fourth carpal bone). Half of the 5-mm sections were stained with haematox-
ylin and eosin (H&E) and the remainder was stained with Safranin O-Fast
Green (SOFG). Sections stained with H&E were evaluated blindly for articu-
lar cartilage ﬁbrillation, chondrocyte necrosis, chondrone formation (chondro-
cyte division within a lacuna), and focal loss of cells (each outcome graded
0e4)11.
Articular cartilage sections stained with SOFGwere evaluated blindly for in-
tensity of staining in the tangential, intermediate, radiate territorial, and radiate
interterritorial zones.Numeric values ranging from0 to4were assigned toeach
variable (0 indicated no stain uptake and 4 indicated normal stain uptake).ARTICULAR CARTILAGE MATRIX EVALUATIONTo estimate articular cartilage proteoglycan content, the total articular car-
tilage GAG content was measured by use of a previously reported 1,9-dime-
thylmethylene blue technique11. Radiolabeled SO4 (
35SO4) incorporation
was also measured by use of previously reported methods11. Samples
were processed in duplicate and the results were reported as counts per min-
ute (cpm) per mg of dry weight.STATISTICAL ANALYSISThe data from the exercise-alone group was analyzed to compare any dif-
ferences between left and right sham operated limbs using a general linear
model analysis of variance with the horse serving as a random effect. Be-
cause no signiﬁcant differences were noted in these analyses the limbs
from the exercise-alone group were considered similar. Thus, for synovial
ﬂuid biomarkers, three groups were deﬁned for statistical analysis of limb re-
lated outcome parameters: exercise-alone (sham operated limbs) (n¼ 16),
OA-affected (n¼ 8), exercise-alone joints of OA-affected horses (n¼ 8).
This model allowed determination of a systemic effect within each group
(i.e., does the OA-affected joint inﬂuence outcome parameters from the con-
tralateral sham operated joint). A split plot with repeated measures design
was used as the statistical model to evaluate the dependent variables over
time. Outcome variables recorded at a single time point were subjected to
a general linear model procedure analysis of variance. In all cases analyzing
independent variables for both the main and the interaction effects on the de-
pendent variables were performed.
For outcome parameters measured in the serum, the effect of exercise
and OA were considered in the analyses. A split plot design with repeated
measures analysis was used as the statistical model to evaluate the depen-
dent variables. Furthermore, proc Mixed (SAS, version 8e, Carey, NC, USA)
was used to perform a general linear mixed model analysis of variance for
statistical comparisons. The independent variables in this model were day
of sample collection and exercise-alone operated or OA-affected groups.
The subject within-exercise/exercise OA was used as a random effect vari-
able. In all analyses the highest interaction of the independent variables
with P< 0.05 was considered the most signiﬁcant and was reported.
When there was a signiﬁcant interaction effect, a Least Square Means test
was used to make individual comparisons. A Pearson correlation coefﬁcients
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LA signiﬁcant increase in lameness, response to carpal
ﬂexion and effusion were demonstrated in the OA-affected
limbs/joints. The exercise-alone joints in the OA-affected
horses had a signiﬁcant increase in response to ﬂexion by
the termination of the study when compared to pre-study
values, as did the exercise-alone joints of the exercise-
alone horses, but this response was signiﬁcantly lower
compared to the exercise OA-affected joints. The degree
of joint effusion increased (but not signiﬁcant) in all horses
following the onset of treadmill exercise; exercise-alone
joints returned to pre-study effusion levels by day 84, while
exercise-alone joints in OA-affected horses maintained
a similar effusion level post surgery [Fig. 1(a)]. The OA-
affected joints maintained a constant level of effusion post
surgery that was signiﬁcantly elevated compared to both
other groups throughout the remainder of the study.c
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Fig. 1. (a) Plot of average effusion score S.E.M. by study day.
Study days that have any bar with ‘‘#’’ symbols represent a
signiﬁcant change in all three groups (exercise-alone joints in
exercise-alone horses, exercise-alone joints in OA-affected horses,
OA-affected joints) compared to day 0 value. Bars with ‘‘@’’ symbol
represent signiﬁcant change compared to exercise-sham operated.
Bars with ‘‘*’’ symbol represent signiﬁcant change compared to both
exercise-alone joints in exercise-alone horses and exercise-alone
joints in OA-affected horses. (b) Plot of average WBC S.E.M.
and (c) total protein S.E.M. by study day. Study days that have
any bar with ‘‘#’’ symbols represent a signiﬁcant change in all three
groups (exercise-alone joints in exercise-alone horses, exercise-
alone joints in OA-affected horses, OA-affected joints) compared
to day 0 value. Bars with ‘‘*’’ symbol represent signiﬁcant change
compared to both exercise-alone joints in exercise-alone horses
and exercise-alone joints in OA-affected horses.Results of routine synovial ﬂuid analysis indicated no sig-
niﬁcant differences in synovial ﬂuid color or clarity. The total
WBC for all joints increased signiﬁcantly in the 2 weeks fol-
lowing surgery. Exercise-alone joints of the OA-affected
horses and the exercise-alone horses returned to pre-study
levels but the OA-affected joints remained signiﬁcantly ele-
vated compared to the other groups and pre-study levels
[Fig. 1(b)]. Similarly, within 14 days of surgery the total protein
level in OA-affected joints was signiﬁcantly elevated when
compared to both exercise-alone joints in both OA-affected
and exercise-alone joints, and these values remained signif-
icantly elevated for the duration of the study [Fig. 1(c)]. Exer-
cise induced a signiﬁcant increase in synovial ﬂuid CS846,
CPII, GAG, Col CEQ, C1,2C, osteocalcin and Col I with exer-
cise which persisted once it increased but no increase in
PGE2 (except day 14) and CTX1 (Fig. 2). The levels of
CS846, CPII, GAG, Col CEQ, C1,2C, osteocalcin, Col I and
PGE2 in the OA-affected joints were signiﬁcantly elevated
(within 14, 7, 42, 56, 56, 91 and 35 days, respectively) and re-
mained elevated throughout the study when compared to
both the exercise-alone joints in exercise-alone and OA-af-
fected horses at similar study periods (Fig. 2).
Concentrations of Col I were signiﬁcantly elevated in the
OA-affected joints compared to exercise-alone joints and
these differences remained throughout the duration of the
study. There was no increase in PGE2 levels with exercise
but within 35 days the PGE2 concentrations were signiﬁ-
cantly elevated in the OA-affected joints compared to the
exercise-alone joints; this difference remained signiﬁcant
for the duration of the study. There were no signiﬁcant in-
creases in CTX1 levels with exercise or with OA and there-
fore these data are not presented graphically.
Signiﬁcant correlations were observed between various
biomarkers. Speciﬁcally, CS846 levels showed signiﬁcant
mild correlations with CPII (r¼ 0.50), GAG (r¼ 0.46), Col
CEQ (r¼ 0.37) and PGE2 (r¼ 0.36). Concentrations of
CPII demonstrated a strong signiﬁcant correlation with ColCEQ (r¼ 0.82) and a moderate correlation with PGE2
(r¼ 0.68) aswell as GAG (r¼ 0.64) concentrations. The con-
centrations of GAG had mild signiﬁcant correlations with Col
CEQ (r¼ 0.49) and PGE2 (r¼ 0.36). A signiﬁcant strong cor-
relation both type II collagen degradation (Col CEQ)
(r¼ 0.92) and Col I degradation products (r¼ 0.90) and the
combination of C1,2C was demonstrated. A moderate signif-
icant correlation between Col CEQ and PGE2 (r¼ 0.59) was
seen. All other biomarker to biomarker correlation compari-
sons were not shown to be statistically signiﬁcant.
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Fig. 2. Plot of average synovial ﬂuid CS846, CPII, GAG, Col CEQ, C1,2C, osteocalcin, Col I and PGE2 levels S.E.M. by study day. Study days
that have any bar with ‘‘#’’ symbols represent a signiﬁcant change in all three groups (exercise-alone joints in exercise-alone horses, exercise-
alone joints in OA-affected horses, OA-affected joints) compared to day 0 value. Bars with ‘‘*’’ symbol represent signiﬁcant change compared
to both exercise-alone joints in exercise-alone horses and exercise-alone joints in OA-affected horses.
1199Osteoarthritis and Cartilage Vol. 16, No. 10SERUM BIOMARKERSThe concentrations of CS846, CPII, GAG, C1,2C, osteo-
calcin and Col I (within 7, 14, 7, 42, 42 and 42 days, respec-
tively) increased signiﬁcantly following the onset of
exercise. Col CEQ only increased signiﬁcantly with exercisein the last week of the study and there was no clear pattern
with CTX1. There was also a signiﬁcant increase in CS846,
CPII, GAG, C1,2C, osteocalcin and Col I levels (days 35,
42, 49, 84, 91 and 63, respectively) in OA-affected horses
compared to exercise-alone horses that persisted beyond
1200 D. D. Frisbie et al.: Biomarkers with osteoarthritis in horsesthese initial increases. There was no signiﬁcant increase in
Col CEQ or CTX1 levels in OA-affected horses. A strong
signiﬁcant correlation between CS846 and CPII concentra-
tions was also observed (r¼ 0.77) (Fig. 3).COMPARISON OF SYNOVIAL FLUID AND SERUM
BIOMARKER LEVELSSigniﬁcant correlations were demonstrated between sy-
novial ﬂuid and serum biomarker levels (Table I). The
levels of osteocalcin, C1,2C, and Col I in serum compared
to synovial ﬂuid were 10%, threefold and ninefold higher,
respectively, for exercise-OA horses serum compared to
the exercise OA-affected synovial ﬂuid. This is in compar-
ison to the mean levels of CPII, Col CEQ, CS846, and14 21 28 35 42 49 56 63 70 77 84 91
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Fig. 3. Plot of average CS846, CPII, GAG, C1,2C, osteocalcin, Col CEQ,
have any bar with ‘‘#’’ symbols represent a signiﬁcant change with exerc
pared to day 0 value. Bars with ‘‘*’’ symbol represent signiﬁcant chanGAG which were 50%, 10-fold, 20-fold, and threefold
higher, respectively, in the synovial ﬂuid compared to the
serum for exercise-sham operated horses and 70%, 23-
fold, 22-fold and threefold higher in exercise OA-affected
synovial ﬂuid compared to serum for the same horses.
The levels of CPII, Col CEQ, CS846, and GAG in exercise
OA-affected synovial ﬂuid compared to serum for the same
horses was 70%, 23-fold, 22-fold, and threefold higher,
respectively.GROSS PATHOLOGIC OBSERVATIONS AND CORRELATION
WITH BIOMARKERSAt necropsy examination, full thickness articular cartilage
ﬁbrillation, synovial membrane hemorrhage and the totalExercise-alone horses
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ise groups (exercise-alone horses, and OA-affected horses) com-
ge in OA-affected horses compared to exercise-alone horses.
Table I
The values of R2 between the synovial fluid and serum biomarkers
among the groups (exercise-alone joints in exercise-alone horses,
exercise-alone joints in OA-affected horses, and OA-affected joints)
Biomarker Synovial ﬂuid
OA-affected joints
vs serum OA-
affected horses
Synovial ﬂuid
exercise-alone
joints in OA-
affected horses
vs serum
Synovial ﬂuid
exercise-alone
joints in exercise-
alone horses
vs serum
Osteocalcin 0.14b 0.1b 0.06b
C1,2C 0.81a 0.56a 0.5a
Col 1-3/4 0.52a 0.22a 0.27a
CPII 0.53a 0.48a 0.15a
234CEQ 0.18a 0.18a 0.01b
CS846 0.44a 0.22a 0.5a
sGAG 0.79a 0.67a 0.69a
Superscript letters denote a P-value less than 0.05 for the slope
of the best ﬁt line when¼ a, conversely a P-value of greater than
0.05 when¼ b.
1201Osteoarthritis and Cartilage Vol. 16, No. 10pathology score were signiﬁcantly elevated in the OA-
affected when compared to the exercise-alone joints (Table
II). When these pathologic observations were compared to
biomarker levels at day 91, strong signiﬁcant correlations
were observed for the degree of total articular cartilage ero-
sion and GAG (r¼ 0.79), CS846 (r¼ 0.79), and CPII
(r¼ 0.77) concentrations in the synovial ﬂuid. Moderate sig-
niﬁcant correlations were observed for total erosion scores
and synovial ﬂuid C1,2C (r¼ 0.68) concentrations. A strong
signiﬁcant correlation was observed for the degree of total
articular cartilage erosion and serum GAG (r¼ 0.77)
concentrations. Moderate signiﬁcant correlations were
observed for total erosion scores and serum CS846
(r¼ 0.73), CPII (r¼ 0.65) and C1,2C (r¼ 0.74) concentra-
tions. No other signiﬁcant correlations were noted between
synovial ﬂuid and serum biomarkers and gross outcome
parameters.HISTOLOGIC EXAMINATIONSSynovial membrane stained with H&E from exercise OA-
affected exercise-alone joints in OA-affected horses
showed signiﬁcantly greater cellular inﬁltration and subinti-
mal vascularity when compared to exercise-alone joints in
exercise-alone horses. There were no other signiﬁcant dif-
ferences in these outcome parameters and no signiﬁcant
correlations between any synovial membrane outcome pa-
rameters and biomarker concentrations.
When articular cartilage samples from three separate
locations were averaged a signiﬁcant increase in articular
cartilage ﬁbrillation, chondrocyte necrosis, chondrone for-
mation, and focal chondrocyte loss was noted when OA-
affected joints were compared to exercise-alone joints.
Differences in the individual locations are also detailed in
Table II.
When all locations were pooled and correlated to bio-
marker concentrations, signiﬁcant correlations that ranged
from mild to moderate in strength were noted for each of
the outcome parameters (Table III).
When the articular cartilage was assessed using histo-
chemical methods (SOFG) a signiﬁcant reduction in Safra-
nin-O stain was noted in three of the four cartilage zones
when OA-affected joints were compared to exercise-alone
joints. Samples obtained from the radial and third carpal
bones demonstrated decreased GAG (SOFG) staining, in
the tangential, intermediate and radiate interterritorialzones when OA-affected joints were compared to exer-
cise-alone joints and samples from the third carpal bones
showed decreased GAG staining in the tangential and ra-
diate interterritorial zones when the OA-affected joints
were compared to the exercise-alone joints in the OA-af-
fected horses (Table II). No other signiﬁcant differences
were observed with any comparison or when samples
from the fourth carpal bone were assessed. Only synovial
ﬂuid GAG concentrations showed signiﬁcant correlations
with SOFG scores; these correlations were mild in
strength; tangential (r¼ 0.45), intermediate (r¼ 0.47), radi-
ate interterritorial (r¼ 0.36) and radiate territorial (r¼ 0.36).
No signiﬁcant correlation between histochemical outcome
parameters and serum biomarker concentrations was
found.Discussion
This study was designed to differentiate changes in syno-
vial ﬂuid and serum biomarkers with exercise compared to
horses with experimental OA. Exercise is part of this OA
model that has been used to evaluate a number of treat-
ments for equine OA11e13. This equine model develops
OA rather quickly and it is recognized that the normal pro-
cess in human clinical cases is longer. However, clinical
OA in the equine athlete also develops quite quickly partic-
ularly when associated with OCF in the same location that
the fragment is created in the model. The authors wanted
to incorporate evaluation of biomarkers as additional out-
come parameters in the model but because of various
changes seen with exercise previously it was considered
important to differentiate the effects of exercise from exer-
cise plus concurrent disease.
It was therefore possible to identify seven synovial ﬂuid
biomarkers that could be used to differentiate experimen-
tally induced OA in the horse from non-diseased joints
and six serum biomarkers that could differentiate experi-
mental OA-affected horses from exercise-alone horses.
Whereas there were correlations between synovial effu-
sion and synovial ﬂuid biomarkers, serum biomarker levels
showed signiﬁcant correlations with lameness and re-
sponse to ﬂexion but not synovial effusion. Synovial effu-
sion is generally considered a reﬂection of synovitis but
these serum biomarkers are not considered markers of
synovitis.
This study involved repeated arthrocenteses. The
inﬂuence of repeated arthrocentesis has been previously
examined as a potential confounding factor with the syno-
vial ﬂuid markers NO, PGE2 and GAG concentrations33.
Those authors noted that an increase in NO, PGE2 and
GAG concentrations with repeated arthrocentesis. An
earlier study also showed an increase in matrix metallo-
proteinase 1 (MMP-1) was signiﬁcantly associated with
repeated arthrocentesis (within 60 h)34. Overall these
effects were short term in that NO levels in the metacarpo-
phalangeal (MCP) joint peaked 12 h after previous arthro-
centesis, the increase in PGE2 persisted for 60 h and the
authors concluded it had passed after 2 weeks. We feel
that any effect of arthrocentesis was minor in our study
due to arthrocentesis being 1 week apart.
There has been some attention to changes in biomarkers
with exercise in horses. Levels of carboxy terminal propep-
tide (PICP) biomarker of Col I synthesis have been shown to
decrease signiﬁcantly with age and increase with exercise
when compared to non-exercised horses18,19. On the
other hand osteocalcin levels were lower at the end of
Table II
Outcome variable data (mean S.E.M.) of gross pathologic observations and histologic examinations for comparison of exercise-alone joints in
exercise-alone horses, exercise-alone joints in OA-affected horses, and OA-affected joints
Outcome variable Exercise-alone joints
in exercise-alone horses
(mean S.E.M.)
Exercise-alone joints
in OA-affected horses
(mean S.E.M.)
OA-affected joints
(mean S.E.M.)
Gross pathologic observations
Full thickness articular cartilage ﬁbrillation 0.20b 0.3 0.50b 0.3 1.71a 0.3
Hemorrhage 0.80b 0.3 0.66b 0.3 1.28a 0.3
Total pathology score 0.30b 0.3 0.50b 0.3 1.28a 0.3
Histologic examinations
Synovial membrane 0.18b 0.3 0.50a 0.3 0.50a 0.3
Cellular inﬁltration
Synovial membrane 0.68b 0.3 1.12a 0.3 1.00a 0.3
Subintimal vascularity
Synovial membrane intimal 1.31a 0.3 1.37a 0.3 1.50a 0.3
Hyperplasia
Synovial membrane 1.12a 0.3 1.00a 0.3 1.00a 0.3
Subintimal edema
Synovial membrane 1.31a 0.3 1.37a 0.3 1.50a 0.3
Subintimal ﬁbrosis
Cartilage morphology e radial carpal bone
Fibrillation 0.00b 0.3 0.25a 0.3 0.37a 0.3
Chondrocyte necrosis 0.37a 0.3 0.37a 0.3 0.50a 0.3
Chondrone formation 0.12b 0.3 0.12b 0.3 0.50a 0.3
Focal chondrocyte loss 0.50b 0.3 0.50b 0.3 1.37a 0.3
Cartilage morphology e third carpal bone
Fibrillation 0.00b 0.4 0.46b 0.4 1.12a 0.5
Chondrocyte necrosis 0.62b 0.4 0.62b 0.4 1.62a 0.5
Chondrone formation 0.12b 0.4 0.25b 0.4 1.37a 0.5
Focal chondrocyte loss 0.75b 0.4 0.87b 0.4 1.87a 0.5
Cartilage morphology e fourth carpal bone
Fibrillation 0.00a 0.3 0.00a 0.3 0.12a 0.3
Chondrocyte necrosis 0.37a 0.3 0.50a 0.3 0.50a 0.3
Chondrone formation 0.00a 0.3 0.00a 0.3 0.00a 0.3
Focal chondrocyte loss 0.50a 0.3 0.62a 0.3 0.62a 0.3
SOFG staining e radial carpal bone
Tangential 1.42a 0.6 1.25a 0.6 0.62b 0.6
Intermediate 3.00a 0.6 2.50a 0.6 1.62b 0.6
Radiate territorial 2.85a 0.6 2.75a 0.6 2.50b 0.6
Radiate interterritorial 2.85a 0.6 2.62a 0.6 1.87b 0.6
SOFG staining e third carpal bone
Tangential 1.62a 0.6 0.75b 0.6 0.25c 0.6
Intermediate 2.50a 0.6 2.37a 0.6 1.50c 0.6
Radiate territorial 2.62a 0.6 2.50a 0.6 2.50a 0.6
Radiate interterritorial 2.62a 0.6 1.87b 0.6 1.25c 0.6
SOFG staining e fourth carpal bone
Tangential 1.37a 0.6 1.50a 0.6 1.25a 0.6
Intermediate 2.75a 0.6 2.75a 0.6 2.25a 0.6
Radiate territorial 2.87a 0.6 3.00a 0.6 2.12a 0.6
Radiate interteritorial 2.50a 0.6 2.50a 0.6 2.50a 0.6
Superscript letters that are different show a signiﬁcant difference (P-value< 0.05) between treatment groups for each outcome variable.
Table III
Values of R2 between articular cartilage histopathologic variables
and synovial fluid biomarkers
Biomarker Fibrillation Cell necrosis Chondrone Cell loss
CS846 0.36a 0.04b 0.03b 0.49a
CPII 0.46a 0.41a 0.44a 0.01b
sGAG 0.53a 0.1b 0.04b 0.41a
C1,2C 0.49a 0.41a 0.58a 0.04b
234CEQ 0.48a 0.38a 0.58a 0.04b
PGE2 0.58a 0.53a 0.52a 0.52a
Superscript letters denote a P-value less than 0.05 for the slope
of the best ﬁt line when¼ a, conversely a P-value of greater than
0.05 when¼ b.
1202 D. D. Frisbie et al.: Biomarkers with osteoarthritis in horsesa conditioning period in training horses than in day 1 of the
study20. Serum levels of type I collagen nonhelical telopep-
tide (ICTP) were signiﬁcantly lower in treadmill exercised
horses than controls22 and in a second study in 2-year-old
Thoroughbreds in race training high speed exercise led to
a decrease in serum concentrations in both osteocalcin
and ICTP21. The authors are unaware of any clinical studies
depicting changes with exercise with the biomarkers tested
in this study (other than osteocalcin mentioned above). The
ﬁnding that there were differences with OA compared to ex-
ercise only in seven synovial ﬂuid biomarkers and six serum
biomarkers suggests the possibility of using these bio-
markers to diagnose early disease in horses in training.
1203Osteoarthritis and Cartilage Vol. 16, No. 10However, these studies need to be done in the ﬁeld to as-
certain if this is feasible. At this stage the biomarker
changes can only be applied to the equine OA model that
was tested. It is also to be noted that the histological and
histochemical changes in the articular cartilage in this model
are quite mild and would be less than typically seen in clin-
ical equine OA. Having identiﬁed these series of markers as
useful in an early equine model of OA where the changes in
the articular cartilage are relatively mild a more detailed
study in clinical cases of OA using these biomarkers would
deﬁnitely be appropriate.
It is noteworthy that PGE2 levels were signiﬁcantly in-
creased with experimental OA. Synovial ﬂuid PGE2 levels
have consistently increased in other studies with this exper-
imental model and have been presumed to have been cor-
related with synovitis. Based on the lack of correlation
between synovitis and serum biomarker concentrations as
previously noted (PGE2 is not one of them) PGE2 increase
is probably associated with more than synovial inﬂamma-
tion. With regard to the increase in CS846 and CPII levels
seen in this study it should be noted that a previous study
with clinical OCF in horses had shown an increase in syno-
vial ﬂuid epitope CS846 but no increase in synovial ﬂuid
CPII levels16.
It is particularly useful to ﬁnd serum biomarkers in the
horse that will differentiate OA from exercise alone. This
knowledge can be of major value in screening clinical cases
for OA when the horses are in active training. Routine syno-
vial ﬂuid acquisition is difﬁcult to obtain in elite athletes but
serum sampling is well tolerated. Based on the study the
use of serum CS846, CPII, GAG and C1,2C would be use-
ful for detecting early OA. On the other hand osteocalcin,
Col CEQ and CTX1 are not.Conﬂict of interest
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